Skip to main content
. Author manuscript; available in PMC: 2022 May 1.
Published in final edited form as: Tob Control. 2020 Apr 16;30(3):356–358. doi: 10.1136/tobaccocontrol-2019-055571

Table 1.

Excerpts from the January 24, 2018 and January 25, 2018 Tobacco Product Scientific Advisory Committee (TPSAC) meetings that discussed the modified risk tobacco product application for IQOS.

Transcription from January 24, 20189:
DR. WEITZMAN [TPSAC member]: “Please don’t laugh, but in looking at all the documents provided by the FDA and the industry, I don’t know what IQOS means, what it stands for.”
DR. GILCHRIST [PMI representative]: “Doesn’t mean anything.”
DR. WEITZMAN: “Doesn’t mean anything.”
DR. GILCHRIST: “No.”
DR. WEITZMAN: “It’s not an acronym?”
DR. GILCHRIST: “No. In this day and age, it’s very difficult to trademark a new word for naming a product, so you essentially end up with some random letters, and that’s where we are. It doesn’t stand for anything.”
Transcription from January 25, 201825:
DR GILCHRIST: It’s been written in the press that it stand for ‘I Quit Ordinary Smoking’ or ‘I Quit or Switched.’ We’ve seen all of those things. These are all - I think the term is backronyms; these are things people have invented following the use of the trademark IQOS. It’s not true.”